Novartis CEO on how to price lifesaving cell and gene therapies

For decades now, the health-care industry, government and society have grown accustomed to a model for how diseases are treated. Scientists achieve a medical breakthrough, the biopharmaceutical industry develops a medicine, a doctor diagnoses a patient and the patient goes on a course of treatment that can last for years or a lifetime. This model has improved health dramatically across the globe over the last century. Yet we generally could not cure devastating diseases.

Source link

Leave a Comment

Loxo, Bayer drug for cancers driven by rare mutation gets U.S. nodCancer care: England still lagging behind the best